SHINE SA, 6th June 2023 Coping with Gender Dysphoria: A Quick Workbook, is a new peer-led resource by SHINE SA’s Gender Connect Country SA. Coping with gender dysphoria can be a significant challenge for people who are transgender, nonbinary, or gender diverse (TGD). While not all TGD people will experience gender dysphoria in the same way (or at all), gender dysphoria can impact nearly all areas...
World Professional Association for Transgender Health (WPATH), October 2022 Following five-years of rigorous scientific effort by more than 120 health care clinical and academic professionals across the globe, the World Professional Association for Transgender Health (WPATH) has released the Standards of Care for the Health of Transgender and Gender Diverse People, Version 8 (SOC8). Building upon...
SHINE SA, August 2022 Families in Transition: Information Sessions (Face-to-Face and Online) for Parents and Carers of Trans and Gender Diverse Young People Who are these information sessions for? Parents and carers of trans, gender diverse, and questioning (TGD) young people between 12-25 years What will we cover? In a two-hour session, lived experience workers will discuss: • Gender and gender...
SHINE SA, 2022 SHINE SA’s Gender Wellbeing Service is a free, confidential mental health service for people who are questioning their gender identity or identify as trans or gender diverse. (This service provides psychological therapies, peer support, general information and support within the metropolitan area of Adelaide. If you would like to see if you live or work within the Adelaide...
Queensland Human Rights Commission, 2019 This information is for trans and gender diverse employees, their employers, managers and colleagues who are seeking guidance on issues associated with transitioning at work. The guidelines suggest ways to: work together the achieve a successful transition in the workplace; address pre-employment issues; and provide ongoing support to trans employees. Why...
aidsmap/nam, November 9th 2018 A study presented at October’s HIV Research for Prevention conference (HIVR4P) in Madrid shows that transgender women who are taking feminising hormones and also taking pre-exposure prophylaxis (PrEP) have levels of the PrEP drugs tenofovir and emtricitabine in their blood that are about 25% lower than those in cisgender men, and levels in rectal tissue cells...